Research theme for competitive and other funds (6):
高脂血症治療の動脈硬化成因に対する直接作用
冠動脈疾患の危険因子の解析
血清リポ蛋白亜分画代謝
Effects of hypolipoproteinemic treatment on arterioscierosis
Analysis of coronary risk factors
Metabolism of plasma lipoprotein subfractions
Show all
MISC (105):
Relationship between changes in plasma atherosclerotic surrogate markers and changes in triglyceride-rich lipoproteinsby bezafibrate treatment. (Y. Homma, T. Yamashita, H. Yoshida, N. Tada, T. Teramoto, H. Nakamura). 13th International Symposium on Atherosclerosis (Atherosclerosis Suppl). 2003. 4. 2: 320
TG-rich lipoproteins and apo E phenotype in patients with vasospastic angina pectoris. (H. Yamaguchi, Y. Homma, S. Handa). 13th International Symposium on Atherosclerosis (Atherosclerosis Suppl). 2003. 4. 2: 162